This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RAT anti Mouse TLR4/MD-2
catalog :
MCA2154T
quantity :
25 µg
price :
88 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
MTS510
reactivity :
mouse
application :
immunoprecipitation, flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2154T
Description :
RAT ANTI MOUSE TLR4/MD-2
Specificity :
TLR4/MD-2
TargetSpecies :
Mouse
Host :
Rat
Format :
Purified
Isotypes :
IgG2a
Applications :
F, IP
ApplicationTypes :
Immunoprecipitation, Flow Cytometry
Clone :
MTS510
Quantity :
25 µg
QuantityValue :
25
QuantityType :
µg
GOAccessions :
GO:0000187, GO:0001875, GO:0002537, GO:0004888, GO:0007250, GO:0050829, GO:0010552, GO:0010572, GO:0030890, GO:0032497, GO:0032609, GO:0032689, GO:0032700, GO:0032707, GO:0032715, GO:0032720, GO:0032722, GO:0032727, GO:0032728, GO:0032729, GO:0032732, GO:0032733, GO:0032735, GO:0032755, GO:0032760, GO:0032874, GO:0043123, GO:0045087, GO:0045348, GO:0045359, GO:0045362, GO:0045368, GO:0045410, GO:0045429, GO:0045576, GO:0046330, GO:0046696, GO:0051770, GO:0060729, GO:0060907, GO:0070373, GO:0070374, GO:0070430, GO:0070434, GO:0071223
GOTerms :
activation of B cell proliferation, activation of chemokine production, activation of ERK1 and ERK2 cascade, activation of I-kappaB kinase/NF-kappaB cascade, activation of interferon-alpha production, activation of interferon-beta biosynthetic process, activation of interferon-beta production, activation of interferon-gamma production, activation of interleukin-1 biosynthetic process, activation of interleukin-1 production, activation of interleukin-10 production, activation of interleukin-12 production, activation of interleukin-13 biosynthetic process, activation of interleukin-6 biosynthetic process, activation of interleukin-6 production, activation of JNK cascade, activation of MAP kinase, activation of MAPK activity during sporulation, activation of MHC class II biosynthetic process, activation of nitric oxide biosynthetic process, activation of nitric-oxide synthase biosynthetic process, activation of stress-activated MAPK cascade, activation of tumor necrosis factor production, cellular response to LTA, defence response to Gram-negative bacteria, defence response to Gram-negative bacterium, defense response to Gram-negative bacteria, detection of LPS, down regulation of ERK1 and ERK2 cascade, down regulation of interferon-gamma production, down regulation of interleukin-17 production, down regulation of interleukin-23 production, down regulation of interleukin-6 production, down regulation of tumor necrosis factor production, downregulation of ERK1 and ERK2 cascade, down-regulation of ERK1 and ERK2 cascade, down-regulation of interferon-gamma production, downregulation of interferon-gamma production, down-regulation of interleukin-17 production, downregulation of interleukin-17 production, down-regulation of interleukin-23 production, downregulation of interleukin-23 production, down-regulation of interleukin-6 production, downregulation of interleukin-6 production, downregulation of tumor necrosis factor production, down-regulation of tumor necrosis factor production, endotoxin receptor activity, epithelial structure maintenance of intestine, GO:0002226, GO:0004926, Gram-negative antibacterial peptide activity, IFNG production, inhibition of ERK1 and ERK2 cascade, inhibition of interferon-gamma production, inhibition of interleukin-17 production, inhibition of interleukin-23 production, inhibition of interleukin-6 production, inhibition of tumor necrosis factor production, LPS receptor activity, LPS receptor complex, maintenance of intestinal epithelium, MAPK activation, negative regulation of ERK cascade, negative regulation of ERK1 and ERK2 signaling pathway, negative regulation of ERK1 and ERK2 signalling pathway, negative regulation of ERK1 cascade, negative regulation of ERK1/2 cascade, negative regulation of ERK2 cascade, negative regulation of IL-17 production, negative regulation of IL-23 production, negative regulation of IL-6 production, negative regulation of MAPK1 cascade, negative regulation of MAPK3 cascade, negative regulation of type II interferon production, negative regulation TNF production, negative regulation TNF-alpha production, negative regulation tumor necrosis factor-alpha production, nitric oxide production involved in acute inflammatory response, non G protein coupled 7TM receptor activity, non-G-protein coupled 7TM receptor activity, non-G-protein-coupled 7TM receptor activity, nonspecific immune response, positive regulation of B lymphocyte proliferation, positive regulation of B-cell proliferation, positive regulation of B-lymphocyte proliferation, positive regulation of ERK cascade, positive regulation of ERK1 and ERK2 signaling pathway, positive regulation of ERK1 and ERK2 signalling pathway, positive regulation of ERK1 cascade, positive regulation of ERK1/2 cascade, positive regulation of ERK2 cascade, positive regulation of IFN-beta production, positive regulation of IL-1 biosynthesis, positive regulation of IL-1 biosynthetic process, positive regulation of IL-1 production, positive regulation of IL-10 production, positive regulation of IL-12 production, positive regulation of IL-13 biosynthesis, positive regulation of IL-13 biosynthetic process, positive regulation of IL-6 biosynthesis, positive regulation of IL-6 biosynthetic process, positive regulation of IL-6 production, positive regulation of interferon-beta anabolism, positive regulation of interferon-beta biosynthesis, positive regulation of interferon-beta formation, positive regulation of interferon-beta synthesis, positive regulation of interleukin-1 anabolism, positive regulation of interleukin-1 biosynthesis, positive regulation of interleukin-1 formation, positive regulation of interleukin-1 synthesis, positive regulation of interleukin-13 anabolism, positive regulation of interleukin-13 biosynthesis, positive regulation of interleukin-13 formation, positive regulation of interleukin-13 synthesis, positive regulation of interleukin-6 anabolism, positive regulation of interleukin-6 biosynthesis, positive regulation of interleukin-6 formation, positive regulation of interleukin-6 synthesis, positive regulation of major histocompatibility complex class II biosynthesis, positive regulation of major histocompatibility complex class II biosynthetic process, positive regulation of MAPK1 cascade, positive regulation of MAPK3 cascade, positive regulation of MHC class II anabolism, positive regulation of MHC class II biosynthesis, positive regulation of MHC class II formation, positive regulation of MHC class II synthesis, positive regulation of NF-kappaB-inducing kinase activity, positive regulation of nitric oxide anabolism, positive regulation of nitric oxide biosynthesis, positive regulation of nitric oxide formation, positive regulation of nitric oxide synthesis, positive regulation of NO synthase biosynthesis, positive regulation of NO synthase biosynthetic process, positive regulation of NOD1 signaling pathway, positive regulation of NOD2 signaling pathway, positive regulation of NOS biosynthesis, positive regulation of NOS biosynthetic process, positive regulation of nucleotide-binding oligomerization domain containing 1 signalling pathway, positive regulation of nucleotide-binding oligomerization domain containing 2 signalling pathway, positive regulation of p38 MAPK signaling, positive regulation of p38 MAPK signalling, positive regulation of stress-activated MAPK signaling pathway, positive regulation of stress-activated MAPK signalling pathway, positive regulation of stress-activated MAPKKK cascade, positive regulation of stress-activated MAPKKK signaling pathway, positive regulation of stress-activated MAPKKK signalling pathway, positive regulation of TNF production, positive regulation of TNF-alpha production, positive regulation of tumor necrosis factor-alpha production, positive regulation of type II interferon production, production of nitric oxide involved in acute inflammatory response, production of nitric oxide involved in inflammatory response, stimulation of B cell proliferation, stimulation of chemokine production, stimulation of ERK1 and ERK2 cascade, stimulation of I-kappaB kinase/NF-kappaB cascade, stimulation of interferon-alpha production, stimulation of interferon-beta biosynthetic process, stimulation of interferon-beta production, stimulation of interferon-gamma production, stimulation of interleukin-1 biosynthetic process, stimulation of interleukin-1 production, stimulation of interleukin-10 production, stimulation of interleukin-12 production, stimulation of interleukin-13 biosynthetic process, stimulation of interleukin-6 biosynthetic process, stimulation of interleukin-6 production, stimulation of JNK cascade, stimulation of MHC class II biosynthetic process, stimulation of nitric oxide biosynthetic process, stimulation of nitric-oxide synthase biosynthetic process, stimulation of stress-activated MAPK cascade, stimulation of tumor necrosis factor production, type II IFN production, type II interferon production, up regulation of B cell proliferation, up regulation of chemokine production, up regulation of ERK1 and ERK2 cascade, up regulation of I-kappaB kinase/NF-kappaB cascade, up regulation of interferon-alpha production, up regulation of interferon-beta biosynthetic process, up regulation of interferon-beta production, up regulation of interferon-gamma production, up regulation of interleukin-1 biosynthetic process, up regulation of interleukin-1 production, up regulation of interleukin-10 production, up regulation of interleukin-12 production, up regulation of interleukin-13 biosynthetic process, up regulation of interleukin-6 biosynthetic process, up regulation of interleukin-6 production, up regulation of JNK cascade, up regulation of MHC class II biosynthetic process, up regulation of nitric oxide biosynthetic process, up regulation of nitric-oxide synthase biosynthetic process, up regulation of stress-activated MAPK cascade, up regulation of tumor necrosis factor production, upregulation of B cell proliferation, up-regulation of B cell proliferation, upregulation of chemokine production, up-regulation of chemokine production, upregulation of ERK1 and ERK2 cascade, up-regulation of ERK1 and ERK2 cascade, up-regulation of I-kappaB kinase/NF-kappaB cascade, upregulation of I-kappaB kinase/NF-kappaB cascade, up-regulation of interferon-alpha production, upregulation of interferon-alpha production, up-regulation of interferon-beta biosynthetic process, upregulation of interferon-beta biosynthetic process, up-regulation of interferon-beta production, upregulation of interferon-beta production, up-regulation of interferon-gamma production, upregulation of interferon-gamma production, up-regulation of interleukin-1 biosynthetic process, upregulation of interleukin-1 biosynthetic process, up-regulation of interleukin-1 production, upregulation of interleukin-1 production, up-regulation of interleukin-10 production, upregulation of interleukin-10 production, up-regulation of interleukin-12 production, upregulation of interleukin-12 production, up-regulation of interleukin-13 biosynthetic process, upregulation of interleukin-13 biosynthetic process, up-regulation of interleukin-6 biosynthetic process, upregulation of interleukin-6 biosynthetic process, up-regulation of interleukin-6 production, upregulation of interleukin-6 production, upregulation of JNK cascade, up-regulation of JNK cascade, upregulation of MHC class II biosynthetic process, up-regulation of MHC class II biosynthetic process, upregulation of nitric oxide biosynthetic process, up-regulation of nitric oxide biosynthetic process, up-regulation of nitric-oxide synthase biosynthetic process, upregulation of nitric-oxide synthase biosynthetic process, up-regulation of stress-activated MAPK cascade, upregulation of stress-activated MAPK cascade, upregulation of tumor necrosis factor production, up-regulation of tumor necrosis factor production
UniprotAccessions :
Q9QUK6
Gene :
Tlr4
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=21898
EntityFormats :
Purified, ALEXA FLUOR® 488
UNSPSC :
12352203
Concentration :
IgG concentration 0.5 mg/ml
ProductForm :
Purified IgG - liquid
PriceDKK :
655
PrimarySecondary :
Primary
PriceGBP :
62
PriceEUR :
88
PriceUSD :
88 USD
PriceCHF :
103
PriceSEK :
877
PriceNOK :
872
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.